Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (1 ops.)
Latest filing published 24 Oct 2019 for ALDER BIOPHARMACEUTICALS INC, €260k. Read the official filing
Filing timeline
BuySaleErin Lavelle
Insider track record
Disclosed buys
0
Disclosed sells
1
Signal history
Erin Lavelle: trading record in brief
All filings by Erin Lavelle on record concern Alder Biopharmaceuticals Inc. Between 23 April 2019 and 22 October 2019, the trades on record add up to 4 filings.
Every open-market trade on record is a sale: 1 sale worth €18k. The rest of the record consists of 2 share grants.
The latest filing, published on 24 October 2019, reports a transaction of €260k in Alder Biopharmaceuticals Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. Section 16 rules allow two business days to file each Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Erin Lavelle
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations4 total
16,092 shares@ US$18.0093.7% of flowCommon StockSEC:0001209191-19-053922:1
11,684 shares0Common StockSEC:0001209191-19-053922:0
5,842 shares0Common StockSEC:0001209191-19-026034:0
1,434 shares@ US$13.676.3% of flowCommon StockSEC:0001209191-19-026034:1
4 of 4 declarations
